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Background: Statin use to reduce low density lipoprotein cholestrol (LDL-C) lowers risk of recurrent cardiovascular events and improves survival in 
patients with coronary artery disease. Current guidelines call for reduction of LDL-c to <70 mg/dl in the highest risk patients. While those undergoing 
coronary artery bypass surgery (CABG) fit into this category, the use of statin and optimal LCL-c level in those undergoing CABG remains low. The 
current study investigates long term mortality of CABG patients with optimal preoperative statin therapy (LCL-c of <70 mg/dl utilizing Statins) versus 
those without such intervention preoperatively.
Methods: This case-control study consists of 744 veterans who underwent CABG. Electronic medical records from veteran’s administration 
hospitals were used to evaluate the presence or absence of CABG, preoperative statin therapy, and LDL-C levels. Optimal preoperative lipid therapy 
was defined as LDL-c<70 mg/dl using statin. Cox regression survival analysis was employed to assess the relation of optimal lipid therapy to long 
term survival.
Results: The mean age of the study population was 65±8 years and 100% were male. During the mean follow-up of 8±2 years, the overall survival 
rate was 83.5%. Survival rates decreased significantly from those with optimal preoperative statin therapy (93.2%) to those without such therapy 
(71.6%) (p=0.001). After adjustment for conventional risk factors, hazard ratio of death was 0.13 (95%CI 0.07-0.22, p=0.0001) for those with 
optimal preoperative statin therapy compared to those without this therapy.
Conclusions: The current study emphasizes the role of optimal LDL-c and statin therapy preoperatively in patients undergoing CABG and its 
association to improved survival. In addition it identifies optimal preoperative statin therapy of CABG patients as an independent factor associated 
with significant reduction in long term mortality.
